MSCopilot: New smartphone-based digital biomarkers correlate with Expanded Disability Status Scale scores in people with Multiple Sclerosis.

Date publication

juillet 2021

Journal

Multiple sclerosis and related disorders

Auteurs

Membres identifiés du Cancéropôle Est :
Pr DE SEZE Jérôme

Tous les auteurs :
Tanoh IC, Maillart E, Labauge P, Cohen M, Maarouf A, Vukusic S, Donzé C, Gallien P, De Sèze J, Bourre B, Moreau T, Louapre C, Vallée M, Bieuvelet S, Klaeylé L, Argoud AL, Zinaï S, Tourbah A

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/34352512

Résumé

A previous clinical study showed the high specificity, sensitivity and reliability of MSCopilot, a software medical device designed by Ad Scientiam for the self-assessment of people with Multiple Sclerosis (PwMS), compared to the traditional Multiple Sclerosis Functional Composite (MSFC). We conducted further analyses to assess MSCopilot's performance with respect to the Expanded Disability Status Scale (EDSS).

Mots clés

Digital health, Expanded Disability Status Scale (EDSS), Multiple Sclerosis Functional Composite (MSFC), Multiple sclerosis, Smartphone application

Référence

Mult Scler Relat Disord. 2021 Jul 23;55:103164